AMAT
46
6
LB
45
15
GLW
48
2
AZO
50
2
WYNN
15
-11
EXPE
77
5
IVZ
52
6
EBAY
43
3
AMP
66
3
JBHT
63
3
BWA
44
3
PX
66
4
CNP
44
5
UNP
48
6
HBI
52
2
EMR
62
14
BMY
43
2
MHK
46
3
GE
61
4
NOC
45
13
AMAT
46
6
LB
45
15
GLW
48
2
AZO
50
2
WYNN
15
-11
EXPE
77
5
IVZ
52
6
EBAY
43
3
AMP
66
3
JBHT
63
3
BWA
44
3
PX
66
4
CNP
44
5
UNP
48
6
HBI
52
2
EMR
62
14
BMY
43
2
MHK
46
3
GE
61
4
NOC
45
13
Financhill
Back

Exact Sciences 10K Form

Sell
45

EXAS
Exact Sciences

Last Price:
71.51
Seasonality Move:
10.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q EXAS/Exact Sciences Quarterly
2023-11-01 10Q EXAS/Exact Sciences Quarterly
2023-08-01 10Q EXAS/Exact Sciences Quarterly
2023-05-09 10Q EXAS/Exact Sciences Quarterly
2022-11-03 10Q EXAS/Exact Sciences Quarterly
2022-08-02 10Q EXAS/Exact Sciences Quarterly

Receive EXAS News And Ratings

See the #1 stock for the next 7 days that we like better than EXAS

EXAS Financial Statistics

Sales & Book Value

Annual Sales: $2.5B
Cash Flow: $71.2M
Price / Cash Flow: 0
Annual Sales: $17.29
Price / Book: 4.14

Profitability

EPS (TTM): -0.95570
Net Income (TTM): $-175.01M
Gross Margin: $1.85B
Return on Equity: -5.59%
Return on Assets: -2.71%

Exact Sciences Earnings Forecast

Key Exact Sciences Financial Ratios

  • The Gross Profit Margin over the past 26 years for EXAS is 73.83%.
  • The Selling, General & Administrative Expenses for EXAS have been equal to 64.82% of Gross Profit Margin.
  • The Research & Development expenses have been 17.04% of Revenue.
  • The Interest Expense is -11.96% of Operating Income.
  • The Net Earning history of EXAS is -8.17% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Exact Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXAS
CUSIP: 30063P
Website: exactsciences.com

Debt

Debt-to-Equity Ratio: 0.8
Current Ratio: 2.17
Quick Ratio: 1.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 571.44

EXAS Technical Analysis vs Fundamental Analysis

Sell
45
Exact Sciences (EXAS) is a Sell

Is Exact Sciences a Buy or a Sell?

  • Exact Sciences stock is rated a Sell
    The current Exact Sciences [EXAS] share price is $71.51. The Score for EXAS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.